Strengths and Challenges of Secretory Ribonucleases as AntiTumor Agents

Approaches to develop effective drugs to kill cancer cells are mainly focused either on the improvement of the currently used chemotherapeutics or on the development of targeted therapies aimed at the selective destruction of cancer cells by steering specific molecules and/or enhancing the immune re...

Descripción completa

Detalles Bibliográficos
Autores principales: Castro, Jessica, Ribó, Marc, Vilanova, Maria, Benito, Antoni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7828032/
https://www.ncbi.nlm.nih.gov/pubmed/33435285
http://dx.doi.org/10.3390/pharmaceutics13010082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7828032/
https://www.ncbi.nlm.nih.gov/pubmed/33435285
http://dx.doi.org/10.3390/pharmaceutics13010082

Ejemplares similares